The procedures that competent authorities and the Agency will adopt in order to evaluate the information on suspected adverse events that they receive should comply with the measures on good pharmacovigilance practice which should be adopted by the Commission and, as appropriate, be based on a common standard derived from the current Commission guidelines on pharmacovigilance for veterinary medicinal products.
Maidir leis na nósanna imeachta a ghlacfaidh na húdaráis inniúla agus an Ghníomhaireacht chun meastóireacht a dhéanamh ar an bhfaisnéis ar theagmhais dhíobhálacha amhrasta a gheobhaidh siad, ba cheart dóibh bearta i ndáil le dea-chleachtas an fhaireachais cógas a chomhlíonadh, arna ghlacadh ag an gCoimisiún agus, de réir mar is iomchuí, ba cheart dóibh a bheith bunaithe ar chaighdeán coiteann a thagann ó na treoirlínte reatha ón gCoimisiún maidir le faireachas cógas do tháirgí íocshláinte tréidliachta.